SOLICITATION NOTICE
66 -- Calibration Comparison System - Package #1
- Notice Date
- 4/21/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334515
— Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- FDA-SOL-1147552
- Archive Date
- 5/13/2015
- Point of Contact
- Eric Rabinovich, Phone: 2404027631
- E-Mail Address
-
eric.rabinovich@fda.hhs.gov
(eric.rabinovich@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Brand Name or Equal Combined Synopsis and Solicitation PART 1 - INTRODUCTION The United States Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA), Winchester Engineering & Analytical Center (WEAC), has a requirement (BRAND NAME OR EQUAL, FAR 52.211-6 August 1999) to purchase one (1) Holaday HI-2790B Calibration Comparison System, or equivalent unit. All required equipment is part of this unit. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 (STREAMLINED PROCEDURES FOR EVALUATION AND SOLICITATION FOR COMMERCIAL ITEMS), as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. The solicitation number is FDA-SOL-1147552. This solicitation is issued as a Request for Quotation (RFQ), using the Simplified Acquisitions Procedures of FAR 13. The solicitation document/incorporated provisions and clauses are those in effect through the current Federal Acquisition Circular: FAC 2005-81, dated 04/10/2015. The associated North American Industry Classification System (NAICS) Code is - 334515 - Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals; Small Business Size Standard is 500 in number of employees. PART 2 -PRICING SHEET The quoter shall fill out the following pricing sheet for the procurement of one (1) Holaday HI-2790B Calibration Comparison System, or equivalent unit: CLIN Model# Description Unit Price Qty Unit of Issue Price 0001 HI-2790B (or equal) Calibration Comparison System $ 1 EA $ Total Amount $ The price quoted will be all-inclusive (e.g. shipping, warranties, etc.). THE GOVERNMENT HAS THE RIGHT TO AWARD ALL, A PORTION OF, OR NONE OF THE OVERALL REQUIREMENTS ON THE BASIS OF THE AVAILABILITY OF FUNDS. PART 3 - REQUIREMENTS The FDA has a requirement for one (1) Holaday HI-2790B Calibration Comparison System, or equivalent unit. This requirement is being procured as a Brand Name or Equal. Please see the following specifications and salient characteristics. SYSTEM SPECIFICATIONS/SALIENT CHARACTERISTICS: The Calibration Comparison System must include the following components: A. Calibration Comparison System that includes: one (1) Local Calibration Reference Meter, one (1) Power/Control Module, and one (1) Anechoic Test Chamber with slotted-end waveguide antenna and probe rotation fixture. General specifications: The components and/or equipment must be a newly manufactured system, not used and refurbished, or previously used for demonstration. The entire system shall be warranted for parts and labor for 12 months from the start of the maintenance period, which will commence upon delivery and acceptance of the Calibration Comparison System. The system is intended to directly replace the aging and failing Holaday HI-2795A Calibration Comparison System, which has been in use at WEAC for over 20 years. This new unit must be designed to comply with requirements in the Center for Devices and Radiological Health (CDRH) Guide for Establishing and Maintaining a Calibration Constancy Intercomparison System for Microwave Oven Compliance Survey Instruments - Revised March 1988, and must be fully compatible with Holaday HI-1501, HI-1710 and HI-1710A microwave survey instruments. The Contractor shall demonstrate upon installation that the item meets all performance specifications, including the mass spectrometer sensitivity specification. The instrument will not be accepted by the Government until those performance specifications have been met. A. Functional Specifications Calibration Comparison System Calibration Constancy Intercomparison System Requirements as shown in the CDRH Guide for Establishing and Maintaining a Calibration Constancy Intercomparison System for Microwave Oven Compliance Survey Instruments - Revised March 1988. A block diagram of the calibration constancy intercomparison system is provided below (See Figure 1.1). The parenthetical numbers preceding each paragraph below and used within those paragraphs refer to the numbers in the block diagram. (1) Source The source is a microwave generator with (a) an appropriate power output (probably approximately 0.5 to 50 Watts maximum output) that may be variable (either internally or by some external attenuator) and (b) a frequency in the relevant ISM band (915 ± 25 MHz or 2450 ± 50 MHz). Depending on the radiator or anechoic enclosure and on the inherent frequency stability of the source, some control over the source output frequency may be necessary. The source might be a magnetron or klystron oscillator, or might be a low-powered source amplified, e.g., by a traveling wave tube amplifier. However, any type of source with adequately stable or controllable output parameters could be used. (2), (3), (4) Directional Couplers The directional couplers are used to sample a fixed fraction of the power flowing through them in either the forward ·or reverse direction. This fraction should be chosen so as to deliver a signal to items (5), (6), or (7) which is of a magnitude appropriate to the specific device. Furthermore, this fraction (or "coupling factor") must be adequately invariant with frequency over the range of frequency variations of the source. Two of these couplers might be replaced by a single bi-directional coupler if desired. Furthermore, if the source has some built-in frequency monitor, (4) might be eliminated. Couplers (2) and (3) should be adequately insensitive to power flowing in a direction opposite to that intended to be measured (i.e., these couplers should have adequate "directivity"). It is not absolutely necessary that directional couplers be used, however some means of differentiating between forward and reflected power (to allow determination of net radiated power) must be included. (5), (6) Power Meters These power meters must provide repeatable, adequately sensitive, and reliable responses to both absolute levels and relative variation of power. They should be relatively insensitive to frequency variation. It may be necessary to insert attenuators between the directional couplers and the power meters to bring the input to the power meters into an appropriate range. It is not absolutely necessary that power meters be used for these applications. Whatever type of detector is used, some reliable means of calibration must be employed in an annual calibration. In the system illustrated, if the source can be demonstrated to be adequately stable, a single power meter might be alternatively switched to the output of the couplers (2) and (3) by means of a coaxial switch. The power meter or meters and directional couplers form the radiated power monitor (RPM). (7) Frequency Measuring Device Some means must be employed to verify that the frequency of the radiated signal remains within appropriate limits. These limits are closely related to the quality of the anechoic environment (9). If standing waves of considerable magnitude exist within this environment, a change in the frequency of the radiated signal can cause a variation in the spatial distribution of the field and have a significant effect on the reading of a stationary probe in the fixture (10). Thus, the choice of both source (1) and anechoic environment (9) must be made with this phenomenon in mind. Although frequency counters are often available in microwave laboratories, any of several other possibilities might be employed (e.g., a tunable cavity might be used with a crystal or power meter monitoring the output). Clearly, the use of an anechoic environment of appropriate characteristics with an adequately stable source can eliminate the necessity to employ the frequency measuring device shown in the illustration. (8) Radiator Some means of radiating the generated power into space must be provided... Among a multitude of possible devices that might be employed for this purpose are horn, log periodic and dipole antennas, as well as flared or simply open-ended waveguide sections. Considerations in the choice include directivity of the radiator vs. the reflectivity and absorption of the anechoic environment, as well as the frequency response of the radiator vs. the source frequency stability. If a stable source is to be employed, a waveguide or coaxial tuner may be employed to improve the system match to the radiator to minimize reflected power. (9) Anechoic Enclosure An anechoic environment should be provided to minimize the effects of the laboratory environment on the measurement. The quality and size of this anechoic environment will determine the magnitude of the standing wave in the region of the instrument under comparison. (10) Probe-Holding Fixture A stable fixture to hold the instrument being evaluated in a rigid, repeatable position must be employed. This fixture should be made of an electrically non-conductive material to minimize standing waves and perturbations of the fields. In general, the greater the magnitude of the standing wave and the closer the probe to the radiator, the more critical are the repositioning requirements of this fixture. Figure 1.1 Delivery Period: Within sixty (60) days after contract award. Place(s) of Delivery: One complete Calibration Comparison System to be shipped to and located at the following laboratory: Winchester Engineering & Analytical Center (WEAC) 109 Holton Street Winchester, MA 01890 The system must be delivered during normal business hours (M-F, 8:00AM - 4:30 PM EST). The following Federal Acquisition Regulation (FAR) and Health and Human Services Acquisition Regulation (HHSAR) clauses apply to this acquisition. FAR clauses and provisions can be obtained at https://www.acquisition.gov/far/index.html. The provision at FAR 52.212-1, Instructions to Offerors-Commercial Items (Apr 2014), applies to this acquisition with the following addenda to the provision. Period for Acceptance of Quotations: The Quoter agrees to hold the proposed prices firm through September 30, 2015. The provision at FAR 52.212-2, Evaluation-Commercial Items (Oct 2014), is applicable to this requirement. The specific evaluation factors to be included in paragraph (a) of that provision are as follows: The Government will award a contract resulting from this solicitation to the responsible quoter whose quotation meets the specifications listed under Part 3 of this solicitation and is the lowest priced quotation received in response to this solicitation. Therefore, award will be made to the quoter whose quotation is determined to be the Lowest Price-Technically Acceptable quotation. A written notice of award or acceptance of a quotation mailed or otherwise furnished to the successful quoter within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. The Provision at FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (March 2015), applies to this acquisition. The quoter shall complete only paragraph (b) of this provision if the Quoter has completed the annual representations and certification electronically via the System for Award Management (SAM) website accessed through http://www.acquisition.gov. If the Quoter has not completed the annual representations and certifications electronically, the Quoter shall complete only paragraphs (c) through (p) of this provision. The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Dec 2014), applies to this acquisition with the following addenda: Invoice Submission: A. The Contractor shall submit one original copy of each invoice to the address specified below: ATTN: FDA Vendor Payments Team Office of Financial Services Food and Drug Administration 8455 Colesville Road 8th Floor, Room 8035A Silver Spring, MD 20910-3311 Fax: 866-807-3742 or 301-827-3742 fdavendorpaymentsteam@fda.gov B. Invoices submitted under this contract must comply with the requirements set forth in FAR Clauses 52.232-25 (Prompt Payment) and 52.232-33 (Payment by Electronic Funds Transfer - System for Award Management) and/or applicable Far Clauses specified herein. To constitute a proper invoice, the invoice must be submitted on company letterhead and include each of the following: (I) Name and address of the contractor; (II) Invoice Date and Invoice Number; (III) Purchase order/Award Number; (IV) Description, Quantity, Unit of Measure, Unit Price, and Extended Price Supplies Delivered or Services Performed, including: (a) Period of Performance for which costs are claimed; (b) Itemized travel costs, including origin and destination; and (c) Any other supporting information necessary to clarify questionable expenditures; (V) Shipping number and date of shipping, including the bill of lading number and weight of shipment if shipped on government bill of lading; (VI) Terms of any discount for prompt payment offered; (VII) Name and address of official to whom payment is to be sent (must be the same as that in the purchase order/award, or in a proper notice of assignment) (VIII) Name, title and phone number of person to notify in event of defective invoice; (IX) Taxpayer Identification Number (TIN); (X) Electronic Funds Transfer (EFT) banking information, including routing transit number of the financial institution receiving payment and the number of the account into which funds are to be deposited; (XI) Name and telephone number of the FDA Contracting Officer Representative (COR) or other program center/office point of contact, as referenced on the purchase order; and, (XII) Any other information or documentation required by the purchase order/award. C. QUESTIONS REGARDING INVOICES SHALL BE DIRECTED TO THE FDA AT THE TELEPHONE NUMBER PROVIDED ABOVE. The clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Items (Apr 2015), applies to this acquisition. The following additional FAR clauses cited in the clause are applicable to the acquisition: (b) 52.203-13, Contractor Code of Business Ethics and Conduct (Apr 2010) (Pub. L. 110-252, Title VI, Chapter 1 (41 U.S.C. 251 note)). 52.222-21 Prohibition of Segregated Facilities (Apr 2015) 52.222-26 Equal Opportunity (Apr 2015) (E.O. 11246) 52.222-35 Equal Opportunity for Veterans (Jul 2014) (38 U.S.C. 4212) 52.222-36 Equal Opportunity for Workers with Disabilities (Jul 2014) (29 U.S.C. 793) 52.223-18 Encouraging Contractor Policies to Ban Text Messaging while Driving (Aug 2011) (E.O. 13513) 52.232-33 Payment by Electronic Funds Transfer- System for Award Management (Jul 2013) (31 U.S.C. 3332) FAR 52.211-6 Brand Name or Equal (Aug 1999) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) The following HHSAR clauses apply to this acquisition and can be obtained at the following website: http://farsite.hill.af.mil/VFHHSAR1.html 352.202-1 Definitions (Jan 2006) 352.203-70 Anti-lobbying (Jan 2006) 352.215-70 Late proposals and revisions (Jan 2006) 352.223-70 Safety and health (Jan 2006) 352.224-70 Privacy Act (Jan 2006) 352.228-7 Insurance--Liability to third persons (Dec 1991) 352.233-71 Litigation and claims (Jan 2006) 352.242-73 Withholding of contract payments (Jan 2006) 352.242-71 Tobacco-free Facilities (Jan 2006) 352.242-74 Final decisions on audit findings (Apr 1984) 352.270-1 Accessibility of meetings, conferences and seminars to persons with disabilities (Jan 2001) The supplies delivered hereunder will be inspected and accepted at destination by the Contracting Officer's Representative (COR) specified at award. If the supplies or services are acceptable, the COR shall promptly forward a report of inspection and acceptance to the paying office. If the supplies or services are not acceptable, the COR shall document the nonconforming items/services and immediately notify the contracting officer. The COR name will be provided at time of award. The COR is responsible for: (1) monitoring the Contractor's technical progress, including the surveillance and assessment of performance and recommending to the Contracting Officer changes in requirements; (2) interpreting the Statement of Work and any other technical performance requirements; (3) performing technical evaluation as required; (4) performing technical inspections and acceptances required by this contract; and (5) assisting in the resolution of technical problems encountered during performance. The Contracting Officer is the only person with authority to act as agent of the Government under this contract. Only the Contracting Officer has authority to: (1) direct or negotiate any changes in the contract; (2) modify or extend the period of performance; (3) change the delivery schedule; (4) authorize reimbursement to the Contractor any costs incurred during the performance of this contract; or (5) otherwise change any terms and conditions of this contract. It is the quoter's responsibility to monitor the Federal Business Opportunities internet site for the release of an amendment to this combined synopsis/solicitation (if any). Quoters that fail to complete the required representations and certifications, or reject the terms and conditions of the solicitation, may be excluded from award consideration. All responsible sources may submit a quote, which, if timely received, will be considered. The quote must reference solicitation number FDA-SOL-1147552. Questions deadline: All questions are to be submitted via email to eric.rabinovich@fda.hhs.gov by no later than April 24, 2015 by 3:00 pm ET. The quotes are due by email to the point of contact listed below by no later than April 28, 2015, 5:00 pm, Eastern Time. Please contact Eric Rabinovich by email at Eric.Rabinovich@fda.hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA-SOL-1147552/listing.html)
- Place of Performance
- Address: Winchester Engineering & Analytical Center (WEAC), 109 Holton Street, Winchester, Massachusetts, 01890, United States
- Zip Code: 01890
- Zip Code: 01890
- Record
- SN03705644-W 20150423/150421234757-bbccc0c2c869cfb363c5c296868dc2cd (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |